COVID vaccine updates for Pfizer-BioNTech, CureVac and Sinovac; plus Disbrow becomes permanent BARDA director
Pfizer pilot program for vaccine distribution
Pfizer Inc. (NYSE:PFE) has launched a pilot program in Rhode Island, Texas, New Mexico and Tennessee to determine ways to refine national BNT162b2 delivery and deployment. The four states were chosen because of their differences in overall size, population diversity and immunization infrastructure as well as their need to reach individuals in varied urban and rural settings. They will not receive vaccine doses earlier than other states and will not receive preferential consideration. The pharma has a license to the vaccine from BioNTech SE (NASDAQ:BNTX).
CureVac ramping up vaccine production
CureVac N.V. (NASDAQ:CVAC) said it is expanding its manufacturing network, including the number of CDMOs, to enable production of up to 300 million doses of mRNA-based vaccine CVnCoV in 2021 and up to 600 million doses in 2022. The company plans to start a pivotal trial of the candidate before year-end...